Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-03-18
1989-10-31
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
048778060
ABSTRACT:
The method which comprises administering to a tumor-containing animal derivatives of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives, preferably a compound having the following structural formula: ##STR1## or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4670461 (1987-06-01), Haugwitz et al.
"The Structure of the Benzene-Maleimide Photosynthetic Product (Mitindomide)", George R. Pettit, Kenneth D. Paull, Cherry L. Herald, Delbert L. Herald and Joseph R. Riden, Cancer Research Institute and Department of Chemistry, Arizona State University, pp. 2291-2294.
"Screening at the National Cancer Institute", Abraham Goldin, John M. Venditti and Stephen K. Carter, National Cancer Institute Monograph: USA-USSR.
Neighbors Ralph P.
Riden Joseph R.
Chevron Research Company
Goldberg Jerome D.
LandOfFree
Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-626329